On Monday, Shares of Oracle Corporation (NYSE:ORCL), lost -0.15% to $40.15.
Oracle Corporation’s stock had its earnings estimate lowered at Canaccord to $2.55 from $2.60 per share in 2015, with 2016 earnings reduced to $2.72 from $2.75 per share.
The firm noted the fourth quarter earnings disappointment and its recent sell-off and trimmed its estimates accordingly.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
Shares of Oncolytics Biotech Inc. (NASDAQ:ONCY), inclined 16.69% to $0.63, during its last trading session.
Oncolytics Biotech, declared that Dr. Devalingam Mahalingam of the Cancer Therapy and Research Centre, University of Texas Health Science Centre San Antonio, made a poster presentation at the ESMO World Congress on Gastrointestinal Cancer. The poster, titled “Oncolytic Virus Therapy in Pancreatic Cancer: Clinical Efficacy and Pharmacodynamic Analysis of REOLYSIN® in Combination with Gemcitabine in Patients with Advanced Pancreatic Adenocarcinoma,” covers final results from the Company’s REO 017 Phase 2 study.
Highlights of the data presented comprise:
- A survival analysis for 33 patients showing a median progression free survival (PFS) of four months and median overall survival (OS) of 10.2 months;
- Data showing one- and two-year survival rates of 45% and 24%, respectively; and
- An analysis demonstrating upregulation of immune checkpoint marker PD-L1 in post treatment tumours suggesting the potential to combine oncolytic viral therapy with anti-PD-L1 inhibitors in future trials.
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a cancer therapeutic that is in various clinical trials for human use.
Finally, Wyndham Worldwide Corporation (NYSE:WYN), ended its last trade with -0.48% loss, and closed at $83.01.
Wyndham Vacation Rentals, the world’s largest professional manager of vacation rental properties and part of the Wyndham Worldwide family of brands (WYN), declared that it has attained ResortQuest Whistler. The acquisition marks the company’s first foray into Canada and adds nearly 600 condominium units to its growing portfolio of vacation rental properties.
“We are delighted to enter the market in Canada and to welcome ResortQuest Whistler to the Wyndham Vacation Rentals family,” said Mary Lynn Clark, president, Wyndham Vacation Rentals North America. “Whistler joins the already impressive list of world-class ski destinations where we offer travellers the comfort and convenience of a vacation rental together with the peace-of-mind that comes with booking your trip with a trusted hospitality company.”
ResortQuest Whistler is the largest vacation rentals manager in the Resort Municipality of Whistler. The company manages a collection of fully-furnished properties that offer amenities like full kitchens, fireplaces and spacious living areas. Its accommodations place guests at the center of the outdoor action from skiing and snowboarding in the winter to mountain biking, hiking and golfing the rest of the year.
Wyndham Worldwide Corporation provides hospitality services and products to individual consumers and business customers worldwide. It operates three in segments: Lodging, Vacation Exchange, and Rentals, and Vacation Ownership.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
